Ayogo Health Inc. develops games and applications for management of chronic health conditions and patient adherence. Its products include GoodLife, a customizable platform that uses tailor-made gamification components, incentives, and social features; and Alternate Reality Games, a suite of learning applications which combines online and real-world elements. The company was founded in 2008 and is based in Vancouver, Canada.
Neosensory, Inc. is a company that specializes in developing wearable devices aimed at enhancing sensory perception for individuals. Founded in 2015 and based in San Mateo, California, Neosensory offers products such as Buzz, which utilizes vision-to-touch sensory substitution technology to assist blind individuals. The company focuses on transmitting various data streams to the brain through the sense of touch, leveraging the skin's potential for information delivery. Their innovative approach includes building hearing assistive technology that allows users to perceive sound through vibrations on the skin. Neosensory also provides a companion application for its products, enhancing the user experience and accessibility of information.
ClearDATA is the trusted managed cloud provider, designed for today’s healthcare security needs. More than 350,000 healthcare professionals trust the ClearDATA HIPAA-compliant cloud to safeguard their patient data and power their critical applications.
ClearDATA protects sensitive healthcare data using compliance and security safeguards, purpose-built DevOps automation, and healthcare expertise — all backed by managed cloud services. This ensures healthcare organizations, and the technology providers that support them, are adhering to the highest standards in privacy, security and compliance in the cloud.
Openwater designs and develops MRI-resolution wearables that medical diagnoses and treatments, and a new era of fluid and affordable brain-to-computer communications to consumer electronics manufacturing facilities and techniques. The company was founded in 2016 and is based in San Francisco, California.
InfoBionic, Inc. is a healthcare technology company based in Massachusetts, founded in 2011. It specializes in remote patient monitoring through its MoMe™ platform, which is a cloud-based service designed to enhance the efficiency of cardiac diagnostic services. The MoMe System focuses on cardiac arrhythmia detection, allowing healthcare providers to monitor patients' heart health continuously by streaming electrocardiogram, respiration, and motion data to the cloud for real-time analysis. This technology aims to improve clinical efficiency and patient care by providing physicians with anytime, anywhere access to critical patient data, ultimately facilitating better detection and treatment of cardiac complications.
Openwater designs and develops MRI-resolution wearables that medical diagnoses and treatments, and a new era of fluid and affordable brain-to-computer communications to consumer electronics manufacturing facilities and techniques. The company was founded in 2016 and is based in San Francisco, California.
ClearDATA is the trusted managed cloud provider, designed for today’s healthcare security needs. More than 350,000 healthcare professionals trust the ClearDATA HIPAA-compliant cloud to safeguard their patient data and power their critical applications.
ClearDATA protects sensitive healthcare data using compliance and security safeguards, purpose-built DevOps automation, and healthcare expertise — all backed by managed cloud services. This ensures healthcare organizations, and the technology providers that support them, are adhering to the highest standards in privacy, security and compliance in the cloud.
Oculus Health provides the support, insights, and passion needed for primary care and specialty providers to be successful in a changing health care environment.
They improve patient outcomes and bring joy back to the practice of medicine, all while growing your revenues.
Qstream, Inc. develops a software as a service based mobile sales acceleration software for managing and measuring the human side of sales acceleration. It serves companies in technology, financial services, and life sciences sectors. Qstream, Inc. was formerly known as Spaced Education, Inc. The company was incorporated in 2008 and is based in Burlington, Massachusetts with engineering facilities in Dublin, Ireland; and Hood River, Oregon. It has a sales headquarters in Maidenhead, United Kingdom and an office in San Francisco.
Zipongo is a company focused on promoting healthy eating habits among individuals through personalized food recommendations. Their platform is designed for employers and health plans, providing tools and content that facilitate healthy eating both at home and in the workplace. By offering actionable data and insights on dietary impacts on overall health, Zipongo aims to enhance the well-being of employees and members while contributing to significant reductions in health-related costs. Additionally, the company provides deals on healthy food, recipes, and nutrition tips, further supporting individuals in making better food choices.
InfoBionic, Inc. is a healthcare technology company based in Massachusetts, founded in 2011. It specializes in remote patient monitoring through its MoMe™ platform, which is a cloud-based service designed to enhance the efficiency of cardiac diagnostic services. The MoMe System focuses on cardiac arrhythmia detection, allowing healthcare providers to monitor patients' heart health continuously by streaming electrocardiogram, respiration, and motion data to the cloud for real-time analysis. This technology aims to improve clinical efficiency and patient care by providing physicians with anytime, anywhere access to critical patient data, ultimately facilitating better detection and treatment of cardiac complications.
N-of-One Therapeutics provides cancer care services. Its team of clinicians and scientists works with a network of diagnostic laboratories, research institutions, and cancer experts to provide access to cancer research, medical science, and molecular diagnostic testing. The company conducts research to assess the standard of care and other diagnostic and treatment opportunities for various cancer types.
WellDoc, Inc. specializes in developing technology solutions aimed at managing chronic diseases, particularly diabetes. The company offers DiabetesManager, a patient-centric platform designed to facilitate the coordination of diabetes care between patients and healthcare providers. This platform includes features such as personalized coaching, medication reminders, alerts for out-of-range metrics, and family connectivity, all supported by cloud-based analytics and clinical decision-making tools. Additionally, WellDoc provides BlueStar, a mobile prescription therapy solution that offers real-time guidance for diabetes self-management. The company supports a variety of stakeholders, including private and public payors, pharmaceutical firms, and healthcare systems, with services that encompass clinical requirements, software development, and behavioral health programs. Founded in 2005 and headquartered in Baltimore, Maryland, WellDoc aims to enhance patient outcomes and reduce healthcare costs by integrating clinical and behavioral applications with everyday technologies.
ClearDATA is the trusted managed cloud provider, designed for today’s healthcare security needs. More than 350,000 healthcare professionals trust the ClearDATA HIPAA-compliant cloud to safeguard their patient data and power their critical applications.
ClearDATA protects sensitive healthcare data using compliance and security safeguards, purpose-built DevOps automation, and healthcare expertise — all backed by managed cloud services. This ensures healthcare organizations, and the technology providers that support them, are adhering to the highest standards in privacy, security and compliance in the cloud.
Ayogo Health Inc. develops games and applications for management of chronic health conditions and patient adherence. Its products include GoodLife, a customizable platform that uses tailor-made gamification components, incentives, and social features; and Alternate Reality Games, a suite of learning applications which combines online and real-world elements. The company was founded in 2008 and is based in Vancouver, Canada.
Gemphire Therapeutics manufactures and markets Gemcabene, an LDL cholesterol-lowering medication. It is a clinical-stage biopharmaceutical company that is committed to helping patients with cardiometabolic disorders, including dyslipidemia and NASH.
The company was founded in 2014 and is based in Northville, Michigan.
Orionis Biosciences operates in the healthcare industry focusing on the biotechnology business and innovation. The company is an early-stage drug discovery and development biotechnology company fueled by a suite of disruptive technologies to advance innovative medicines for the treatment of diseases with high unmet medical needs – with an initial internal focus in oncology and immunotherapies. Orionis Biosciences has research facilities in the Boston area (Headquarters in Waltham, MA, USA) and Ghent (Belgium), and is operated by a world class team of entrepreneurs, scientists and transatlantic network of investors, in concert with strategic research and development collaborations. The latter includes collaborations with VIB (Belgium), Orionis Biosciences co-founding institution.
Aventura intelligently orchestrates assets, people, and systems to deliver the right information at the right time based on location and credentials. It locates and re-assigns the closest online printer and uniquely manages print routing to make it easier to detect and fix printing failures. Aventura was formed in 2007 and headquartered in Denver, Colorado.
Qstream, Inc. develops a software as a service based mobile sales acceleration software for managing and measuring the human side of sales acceleration. It serves companies in technology, financial services, and life sciences sectors. Qstream, Inc. was formerly known as Spaced Education, Inc. The company was incorporated in 2008 and is based in Burlington, Massachusetts with engineering facilities in Dublin, Ireland; and Hood River, Oregon. It has a sales headquarters in Maidenhead, United Kingdom and an office in San Francisco.
Zipongo is a company focused on promoting healthy eating habits among individuals through personalized food recommendations. Their platform is designed for employers and health plans, providing tools and content that facilitate healthy eating both at home and in the workplace. By offering actionable data and insights on dietary impacts on overall health, Zipongo aims to enhance the well-being of employees and members while contributing to significant reductions in health-related costs. Additionally, the company provides deals on healthy food, recipes, and nutrition tips, further supporting individuals in making better food choices.
Aileron Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing and commercializing a novel class of drugs known as stabilized cell-permeating alpha-helical peptides, particularly in the field of oncology. The company’s lead drug candidate, ALRN-6924, is currently undergoing multiple clinical trials, including Phase 2a studies for advanced solid tumors and peripheral T-cell lymphoma, as well as Phase 1 trials for acute myeloid leukemia and advanced myelodysplastic syndrome. Aileron is also working on a next-generation wild type p53 reactivator. Collaborations with notable institutions, such as Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and Pfizer, further enhance its research efforts, particularly in evaluating ALRN-6924 in combination therapies. Aileron Therapeutics was founded in 2001, originally named Renegade Therapeutics, and is headquartered in Watertown, Massachusetts.
Molecular Templates, Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas, dedicated to discovering and developing biologic therapeutics for cancer treatment. The company utilizes a proprietary platform known as engineered toxin bodies to create targeted therapies. Its lead candidate, MT-3724, is currently undergoing Phase II clinical trials for relapsed and refractory diffuse large B-cell lymphoma and non-Hodgkin’s lymphoma. In addition, the company is developing other candidates, including MT-4019, which targets CD38, and has collaborations with Takeda Pharmaceutical Company and Vertex Pharmaceuticals. These partnerships aim to enhance treatment options for conditions like multiple myeloma and improve outcomes in hematopoietic stem cell transplants. Molecular Templates continues to expand its pipeline with additional compounds targeting various cancers.
Aileron Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing and commercializing a novel class of drugs known as stabilized cell-permeating alpha-helical peptides, particularly in the field of oncology. The company’s lead drug candidate, ALRN-6924, is currently undergoing multiple clinical trials, including Phase 2a studies for advanced solid tumors and peripheral T-cell lymphoma, as well as Phase 1 trials for acute myeloid leukemia and advanced myelodysplastic syndrome. Aileron is also working on a next-generation wild type p53 reactivator. Collaborations with notable institutions, such as Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and Pfizer, further enhance its research efforts, particularly in evaluating ALRN-6924 in combination therapies. Aileron Therapeutics was founded in 2001, originally named Renegade Therapeutics, and is headquartered in Watertown, Massachusetts.
ShapeUp is the leading provider of clinically-proven social networking-powered corporate wellness solutions. ShapeUp covers more than 2 million lives on its online platform and serves more than 500 employers and health plans in 109 countries. It was founded in 2006 and headquartered in Providence, Rhode Island.
PathoGenetiX is developing an automated system for the rapid identification of pathogenic bacterial strains using proprietary Genome Sequence Scanning Technology. The company's approach, which employs a single reagent set to generate genomic bar codes based on bacterial DNA, can cost-effectively identify thousands of strains in a single test from complex samples in three hours. PathoGenetiX is developing its GSS platform for use in genomics research, food and product safety testing, and clinical infectious disease diagnostics, with the initial commercial introduction into the research market planned for 2012.
Molecular Templates, Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas, dedicated to discovering and developing biologic therapeutics for cancer treatment. The company utilizes a proprietary platform known as engineered toxin bodies to create targeted therapies. Its lead candidate, MT-3724, is currently undergoing Phase II clinical trials for relapsed and refractory diffuse large B-cell lymphoma and non-Hodgkin’s lymphoma. In addition, the company is developing other candidates, including MT-4019, which targets CD38, and has collaborations with Takeda Pharmaceutical Company and Vertex Pharmaceuticals. These partnerships aim to enhance treatment options for conditions like multiple myeloma and improve outcomes in hematopoietic stem cell transplants. Molecular Templates continues to expand its pipeline with additional compounds targeting various cancers.
Aventura intelligently orchestrates assets, people, and systems to deliver the right information at the right time based on location and credentials. It locates and re-assigns the closest online printer and uniquely manages print routing to make it easier to detect and fix printing failures. Aventura was formed in 2007 and headquartered in Denver, Colorado.
ClearDATA is the trusted managed cloud provider, designed for today’s healthcare security needs. More than 350,000 healthcare professionals trust the ClearDATA HIPAA-compliant cloud to safeguard their patient data and power their critical applications.
ClearDATA protects sensitive healthcare data using compliance and security safeguards, purpose-built DevOps automation, and healthcare expertise — all backed by managed cloud services. This ensures healthcare organizations, and the technology providers that support them, are adhering to the highest standards in privacy, security and compliance in the cloud.
Aileron Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing and commercializing a novel class of drugs known as stabilized cell-permeating alpha-helical peptides, particularly in the field of oncology. The company’s lead drug candidate, ALRN-6924, is currently undergoing multiple clinical trials, including Phase 2a studies for advanced solid tumors and peripheral T-cell lymphoma, as well as Phase 1 trials for acute myeloid leukemia and advanced myelodysplastic syndrome. Aileron is also working on a next-generation wild type p53 reactivator. Collaborations with notable institutions, such as Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and Pfizer, further enhance its research efforts, particularly in evaluating ALRN-6924 in combination therapies. Aileron Therapeutics was founded in 2001, originally named Renegade Therapeutics, and is headquartered in Watertown, Massachusetts.
Activate Networks, Inc. is a network analytics company that identifies and understands the key social connections that drive commercial, organizational, and health results. Activate Networks' suite of analytics products and software enables organizations to unlock the commercial value of their customer, prospect, voter, and employee real-world social networks commonly using data already available in the organization. Activate Networks maps, analyzes, and activates networks across a range of industry verticals, from healthcare to technology, to political campaigns and professional services. Our powerful proprietary RealConnect™ social network analytics platform creates unique, actionable insights that have a direct, measurable impact on marketing campaigns, health-behavior change programs, talent management, innovation, and more.
Cleveland HeartLab, Inc. is a specialty clinical laboratory and disease management company focused on novel biomarker technologies and the creation of proprietary diagnostic tests.
IlluminOss Medical, Inc. is a commercial-stage medical device company offering a unique, minimally invasive technology for fracture repair and stabilization. The Company utilizes a light-curable polymer contained within an expandable balloon to create a patient-conforming intramedullary implant for bone stabilization. The revolutionary, minimally invasive technology is particularly applicable for repair and treatment of patients with osteoporotic and compromised bone. The IlluminOss system is CE-marked and FDA-cleared for a variety of anatomical sites, with further indications pending.
PathoGenetiX is developing an automated system for the rapid identification of pathogenic bacterial strains using proprietary Genome Sequence Scanning Technology. The company's approach, which employs a single reagent set to generate genomic bar codes based on bacterial DNA, can cost-effectively identify thousands of strains in a single test from complex samples in three hours. PathoGenetiX is developing its GSS platform for use in genomics research, food and product safety testing, and clinical infectious disease diagnostics, with the initial commercial introduction into the research market planned for 2012.
MedVentive provides leading-edge technology solutions that enable physician groups, integrated delivery systems, health plans and self-insured employers to effect meaningful and measurable change in the quality and cost of the care they deliver to patients. Founded in 1997 by physicians, MedVentive has been at the forefront of the development of innovative and clinically sophisticated solutions to reduce healthcare costs and improve healthcare quality.
Aventura intelligently orchestrates assets, people, and systems to deliver the right information at the right time based on location and credentials. It locates and re-assigns the closest online printer and uniquely manages print routing to make it easier to detect and fix printing failures. Aventura was formed in 2007 and headquartered in Denver, Colorado.
Lantos Technologies, Inc. specializes in 3D digital ear scanning technology that facilitates the creation of personalized in-ear devices. The company offers the AURA 3D ear scanning system, which is utilized for designing in-ear headphones, musicians' monitors, hearing aids, and noise protection solutions. Lantos Technologies is recognized for having the only FDA-cleared 3D ear scanning system, which enhances the quality and efficiency of custom ear products by capturing detailed measurements from the outer ear to the second bend of the ear canal. Founded in 2009 and based in Derry, New Hampshire, the company was formerly known as Lantos 2.0 Inc. before rebranding in December 2020.
Cleveland HeartLab, Inc. is a specialty clinical laboratory and disease management company focused on novel biomarker technologies and the creation of proprietary diagnostic tests.
PathoGenetiX is developing an automated system for the rapid identification of pathogenic bacterial strains using proprietary Genome Sequence Scanning Technology. The company's approach, which employs a single reagent set to generate genomic bar codes based on bacterial DNA, can cost-effectively identify thousands of strains in a single test from complex samples in three hours. PathoGenetiX is developing its GSS platform for use in genomics research, food and product safety testing, and clinical infectious disease diagnostics, with the initial commercial introduction into the research market planned for 2012.
nanoMR has developed the first system for rapid isolation of rare cells from complex matrices at levels of 1 cell/mL or lower. The immunomagnetic capture system can target multiple cell types simultaneously, for example capturing bacteria and fungi from bloodstream infections, or specific cell types, such as circulating tumor, or fetal, cells, in less than 30 minutes.
SpringLeaf Therapeutics (formerly known as Entra Pharmaceuticals, Inc.) is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on convergent science and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Flybridge Capital Partners and North Bridge Venture Partners.
Catch.com (formerly Snaptic) is a market leader for Android smartphones and tablets. Millions have downloaded our mobile apps, including Catch Notes, AK Notepad and Compass. Our mobile apps also run on iOS and the web, and we are just getting started. Catch.com was founded in 2008 and is on the cusp of a seismic shift driven by growth in smartphone use -- reinventing how people interact, collaborate and discover what’s important to them.
Lantos Technologies, Inc. specializes in 3D digital ear scanning technology that facilitates the creation of personalized in-ear devices. The company offers the AURA 3D ear scanning system, which is utilized for designing in-ear headphones, musicians' monitors, hearing aids, and noise protection solutions. Lantos Technologies is recognized for having the only FDA-cleared 3D ear scanning system, which enhances the quality and efficiency of custom ear products by capturing detailed measurements from the outer ear to the second bend of the ear canal. Founded in 2009 and based in Derry, New Hampshire, the company was formerly known as Lantos 2.0 Inc. before rebranding in December 2020.
ShapeUp is the leading provider of clinically-proven social networking-powered corporate wellness solutions. ShapeUp covers more than 2 million lives on its online platform and serves more than 500 employers and health plans in 109 countries. It was founded in 2006 and headquartered in Providence, Rhode Island.
Viridos is a biotechnology company focused on developing genomic-driven solutions to address global energy and environmental challenges. It utilizes a proprietary RNA replicon platform to stimulate the immune system and deliver targeted therapies produced within the body. The company synthesizes and programs DNA to design and develop microbes for various industrial processes, including bioenergy applications. Its portfolio includes algal-based biodiesel and microbial cultivation technologies that enhance the production and recovery rates of subsurface hydrocarbons. Viridos is also engaged in creating advanced biofuels and harnessing photosynthetic organisms to produce value-added products from sunlight and carbon dioxide. Additionally, it develops biologics such as monoclonal antibodies and therapeutic enzymes, serving clients in the pharmaceutical and biotech sectors, as well as contract manufacturing organizations. Founded in 2005 and based in La Jolla, California, the company aims to improve energy production, chemical synthesis, and pharmaceutical development while contributing to carbon sequestration and environmental remediation efforts.
Catch.com (formerly Snaptic) is a market leader for Android smartphones and tablets. Millions have downloaded our mobile apps, including Catch Notes, AK Notepad and Compass. Our mobile apps also run on iOS and the web, and we are just getting started. Catch.com was founded in 2008 and is on the cusp of a seismic shift driven by growth in smartphone use -- reinventing how people interact, collaborate and discover what’s important to them.
Tetraphase Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing novel antibiotics to combat serious multidrug-resistant infections. Its primary product candidate, Xerava (eravacycline), is a synthetic fluorocycline designed for intravenous use as a first-line treatment for multidrug-resistant infections, particularly those caused by Gram-negative bacteria. The company has conducted Phase III clinical trials, including IGNITE1 and IGNITE4, to evaluate Xerava's safety and efficacy for treating complicated intra-abdominal infections. In addition to Xerava, Tetraphase is advancing other product candidates, such as TP-271, which targets respiratory diseases caused by antibiotic-resistant pathogens, and TP-6076, aimed at treating multidrug-resistant Gram-negative infections. The company holds a licensing agreement with Everest Medicines Limited to develop and commercialize Xerava in various Asian markets. Founded in 2006 and headquartered in Watertown, Massachusetts, Tetraphase Pharmaceuticals is a subsidiary of La Jolla Pharmaceutical Company.
IntraPace, Inc. specializes in the development and marketing of implantable devices aimed at treating obesity. Founded in 2001 and located in Mountain View, California, the company has created the abiliti system, which stimulates a satiety response to facilitate weight loss. This innovative device is based on technology commonly used in cardiac pacemakers and defibrillators, allowing for implantation through standard laparoscopic methods. Notably, the abiliti system does not alter the digestive system's anatomy and imposes no restrictions on a patient's dietary intake, making it a versatile option for individuals seeking weight management solutions.
Saladax Biomedical, Inc. specializes in developing and commercializing diagnostic blood tests aimed at enhancing personalized medicine in psychiatry and oncology. The company offers a range of tests under the MyCare brand, which includes MyCare Psychiatry for determining appropriate antipsychotic dosages, MyCare Oncology for optimizing chemotherapy exposure, and MyCare Neurology for assessing the impact of neurological medications. Notable products include My5-FU, MyPaclitaxel, MyDocetaxel, and MyImatinib, which assist healthcare professionals in managing treatments for various cancers and conditions. Saladax Biomedical markets its products through distributors in regions such as Asia Pacific, the European Union, the Middle East, and North Africa, as well as through direct sales in select areas. Founded in 2004 and based in Bethlehem, Pennsylvania, the company has been providing innovative diagnostic solutions for over 15 years.
TransMedics Group, Inc. is a medical technology company focused on enhancing organ transplant therapies for patients with end-stage organ failure. Headquartered in Andover, Massachusetts, the company has developed the Organ Care System (OCS), a portable technology that maintains donor organs in a near-physiological state during transport. The OCS includes specialized systems for various organs, such as OCS LUNG, which preserves and optimizes lungs; OCS Heart, designed to keep donor hearts metabolically active; and OCS Liver, currently under clinical evaluation for liver transplants. This innovative approach aims to reduce ischemia, improve organ viability, and potentially increase the availability of transplants, addressing critical needs in the field of organ transplantation. TransMedics was founded in 1998 and has positioned itself at the forefront of advancing organ preservation technology.
BIOCIUS Life Sciences, Inc. engages in the drug discovery research. The company was incorporated in 2009 and is based in Woburn, Massachusetts. BIOCIUS Life Sciences, Inc. operates as a subsidiary of BioTrove, Inc.
Virgin Pulse, part of Sir Richard Branson’s Virgin Group, designs technology that cultivates good lifestyle habits for your employees. Configured to complement your culture, our technology, and the overall well-being experience we deliver, drives superior outcomes for your people and your business. Virgin – one of the world’s most recognized and respected brands – is known for creating unrivaled consumer experiences. Conceived in 1970 by Branson, the brand believes in insatiable curiosity, smart disruption, heartfelt service, and delightful experiences.
MedVentive provides leading-edge technology solutions that enable physician groups, integrated delivery systems, health plans and self-insured employers to effect meaningful and measurable change in the quality and cost of the care they deliver to patients. Founded in 1997 by physicians, MedVentive has been at the forefront of the development of innovative and clinically sophisticated solutions to reduce healthcare costs and improve healthcare quality.
Exact Sciences Corporation is a molecular diagnostics company based in Madison, Wisconsin, specializing in cancer screening and diagnostic tests. The company's flagship product is Cologuard, a non-invasive stool-based DNA screening test designed to detect colorectal cancer and pre-cancer. This test is endorsed in the colorectal cancer screening guidelines by the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer. In addition to Cologuard, Exact Sciences offers Oncotype DX, a series of gene expression tests for various cancers, including breast, prostate, and colon cancers, as well as the Oncotype DX AR-V7 Nucleus Detect Test, which is a liquid-based test for advanced stage prostate cancer. The company is actively engaged in research and development to enhance Cologuard's performance and to develop additional blood and fluid-based tests. Exact Sciences has established licensing agreements with institutions such as the MAYO Foundation for Medical Education and Research, Biocartis N.V., and Hologic, Inc.
Aileron Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing and commercializing a novel class of drugs known as stabilized cell-permeating alpha-helical peptides, particularly in the field of oncology. The company’s lead drug candidate, ALRN-6924, is currently undergoing multiple clinical trials, including Phase 2a studies for advanced solid tumors and peripheral T-cell lymphoma, as well as Phase 1 trials for acute myeloid leukemia and advanced myelodysplastic syndrome. Aileron is also working on a next-generation wild type p53 reactivator. Collaborations with notable institutions, such as Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and Pfizer, further enhance its research efforts, particularly in evaluating ALRN-6924 in combination therapies. Aileron Therapeutics was founded in 2001, originally named Renegade Therapeutics, and is headquartered in Watertown, Massachusetts.
BioTrove, Inc. specializes in micro and nano-scale technology platforms designed for life science and drug discovery research. The company provides several key technologies, including OpenArray, which facilitates relative gene expression analysis and supports genomic research across diverse fields such as agriculture, disease research, and public health. Additionally, BioTrove offers RapidFire, a platform that allows for the screening of challenging drug targets through mass spectrometry-based assay development. The RapidFire mass spectrometry hardware system is also part of their offerings, providing native detection technology that aids in drug screening and in vitro ADME applications.
Xcellerex is a supplier of manufacturing technologies, developing and producing biomanufacturing systems and production-scale bioreactors. The biomanufacturing solutions transform the speed and economics of producing therapeutic proteins, including biosimilars and vaccines. Its proprietary products offer significant advantages such as faster installation, lower capital investment, reduced risk of cross-contamination, and significantly increased flexibility compared with traditional manufacturing technologies. The company’s FlexFactory® is a completely modular and portable production train based on single-use technologies, advanced process automation, and compact cleanroom architecture. In 2002, the company was founded by Parrish M. Galliher inMarlborough, Massachusetts.
Carefx's main solution "Fusionfx" helps close information gaps between hospital/IDN CIO and CMIO and healthcare IT departments.
Fusionfx is able to help "synthesize disparate data into clinically relevant, user-centric workflows." The solution aims to connect the data points and make it comprehensive/understandable fo patients, payers, clinicians, and the compliance agencies who seek such information.
Zonare Medical Systems, Inc. specializes in the development, manufacturing, and commercialization of compact ultrasound systems designed for diagnostic imaging across various clinical applications. The company's flagship product, the z.one ultrasound system, utilizes a proprietary technology known as Zone Sonography, which enhances data acquisition and image formation, allowing for upgrades and new clinical applications. Zonare Medical distributes its ultrasound systems through a direct sales force in the United States and a combination of distributors and direct sales personnel in around 40 international markets. Founded in 1999 and headquartered in Mountain View, California, the company was previously known as NovaSonics, Inc.
Skylight Tools, Inc. operates a digital platform that simplifies the process of home renovations by connecting users with general contractors. Founded in 2016 and based in San Francisco, the company offers a comprehensive renovation management tool that assists clients in selecting contractors, managing budgets, and tracking project progress. Their application facilitates payment processing, invoice reconciliation, and real-time updates on project status. Skylight also provides a financial guarantee, covering half of any budget overruns exceeding 10%. The company aims to enhance the renovation experience through a fully integrated digital process that encompasses planning, material selection, permitting, and construction, specifically targeting the challenges associated with traditional renovation methods.
Passport Health Communications, Inc., a software-as-a-service company, provides revenue cycle management solutions and platforms. The company offers eCare Patient Access Suite, including solutions for patient demographic and insurance verification, compliance, and managing patient payments; OrderChecker that validates outpatient diagnosis and procedure codes; and IntelliSource, an integrated patient access system. It also provides OneSource, a Web-based user interface, which enables to verify patient demographic and insurance information, identify coverages, maintain payer compliance, and estimate and collect patient payments; BatchSource that allows for automation to upload, process, and download files for various transactions across the revenue cycle; and Registration Quality Assurance, a Web-based integrated solution, which automatically launches insurance eligibility real-time. In addition, the company offers Patient Payment Estimator that calculates estimates based on price information; eCashiering, a solution for processing patient payments prior to or at the point of service; Claims Management Suite, which provides solutions and services for claims submission, editing, denials, and reimbursements; Payment Navigator, an automated financial screening tool; and OrderRite, a single-user interface to submit, validate, and manage pre-certifications. Further, it provides patient verification, compliance, and payment management services. The company serves health care organizations, including hospitals, physician offices, surgery centers, durable medical equipment facilities, and skilled nursing facilities. Passport Health Communications was formerly known as InterMed, LLC and changed its name to Passport Health Communications, Inc. in 1998. The company was founded in 1996 and is headquartered in Franklin, Tennessee. Passport Health Communications, Inc. operates as a subsidiary of Passport Holding, Corp.
IPC is the nation's leading national physician group practice focused on the delivery of hospital medicine and related facility-based services. IPC providers manage the care of patients in coordination with primary care physicians and specialists in over 1,100 facilities in 28 states across the U.S. We provide care to over 1 million patients annually while maintaining high standards of quality care, aligning with the mission and objectives of the facilities where we serve.
Emageon provides an enterprise-level information technology solution for the clinical analysis and management of digital medical images within health care provider organizations.
Forhealth Technologies is focused on the development of automation technology solutions for the process of intravenous drug preparation. Forhealth Technologies was acquired by Baxa Corporation in March 2009. Forhealth Technologies was founded in 1998 and is based in Daytona Beach, Florida.
RxGen, Inc. is a biotechnology company that develops therapeutics for central nervous system disorders such as neurodegeneration, memory loss, and obesity. The company utilizes PrimaTox, which is a predictive toxicogenomics platform that enables pharmaceutical candidate selection and pre-clinical validation. RxGen is based in Hamden, Connecticut.
CareMedic Systems, Inc. provides revenue cycle management solutions to hospitals and healthcare providers in the United States and Puerto Rico. It offers electronic Financial Record, a healthcare financial management system that provides activity tracking capabilities, and recording descriptions and dates for various events that occur inside or outside the patient accounting system; and VerifyAR, a solution for front-end document management, eligibility verification, compliance checking, and medical necessity review. The company also provides AccelerateAR, a Medicare review and editing solution with document management, all-payer claims formatting and submission, and print and mail service capabilities; and OptimizeAR, a solution that offers tools for managing payments through remittance management, denial management, and paper EOB to electronic 835 conversions. In addition, it offers ImageAR, a document management system with integrated front and back-end scanning, indexing, and storage solutions that enable and streamline various revenue cycle functions; and ResolveAR, a suite of service offerings, including accounts receivables outsourcing, Medicare accounts receivables cleanup, and credit balance resolution. The company provides its solutions in application service provider (ASP) model. CareMedic Systems, Inc. was founded in 1996 and is based in St. Petersburg, Florida with additional offices in Alpharetta and Decatur, Georgia.